New England Journal of Medicine Publishes Complete Results of Positive Phase 2 Trial of Sibeprenlimab in Treatment of Immunoglobulin A Nephropathy (IgAN)
The sibeprenlimab Phase 2 clinical trial results will also be presented this week at the American Society of Nephrology (ASN)...




















